Neogen Corporation (NASDAQ:NEOG) VP Edward Bradley sold 38,876 shares of the company’s stock in a transaction on Wednesday, September 20th. The shares were sold at an average price of $71.28, for a total value of $2,771,081.28. Following the sale, the vice president now owns 83,712 shares of the company’s stock, valued at $5,966,991.36. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Edward Bradley also recently made the following trade(s):

  • On Monday, September 11th, Edward Bradley sold 13,628 shares of Neogen Corporation stock. The shares were sold at an average price of $70.06, for a total value of $954,777.68.
  • On Wednesday, September 6th, Edward Bradley sold 6,372 shares of Neogen Corporation stock. The shares were sold at an average price of $70.05, for a total value of $446,358.60.
  • On Wednesday, July 19th, Edward Bradley sold 5,000 shares of Neogen Corporation stock. The shares were sold at an average price of $66.33, for a total value of $331,650.00.

Shares of Neogen Corporation (NASDAQ:NEOG) opened at 72.93 on Friday. Neogen Corporation has a 12 month low of $50.53 and a 12 month high of $74.98. The company has a market capitalization of $2.79 billion, a P/E ratio of 61.29 and a beta of 1.51. The company’s 50 day moving average price is $68.09 and its 200 day moving average price is $65.57.

Neogen Corporation (NASDAQ:NEOG) last announced its quarterly earnings results on Tuesday, September 19th. The company reported $0.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.30 by $0.01. The company had revenue of $95.30 million during the quarter, compared to analysts’ expectations of $94.87 million. Neogen Corporation had a return on equity of 9.93% and a net margin of 12.28%. The firm’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.26 earnings per share. Analysts expect that Neogen Corporation will post $1.31 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This report was first reported by Daily Political and is owned by of Daily Political. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/09/24/edward-bradley-sells-38876-shares-of-neogen-corporation-neog-stock.html.

A number of institutional investors have recently bought and sold shares of NEOG. First Trust Advisors LP grew its position in Neogen Corporation by 78.2% during the first quarter. First Trust Advisors LP now owns 14,884 shares of the company’s stock worth $976,000 after buying an additional 6,530 shares in the last quarter. Bank of New York Mellon Corp grew its position in Neogen Corporation by 1.7% during the first quarter. Bank of New York Mellon Corp now owns 528,147 shares of the company’s stock worth $34,619,000 after buying an additional 8,880 shares in the last quarter. BNP Paribas Arbitrage SA grew its position in Neogen Corporation by 13.2% during the first quarter. BNP Paribas Arbitrage SA now owns 7,959 shares of the company’s stock worth $522,000 after buying an additional 926 shares in the last quarter. Comerica Bank grew its position in Neogen Corporation by 5.2% during the first quarter. Comerica Bank now owns 45,419 shares of the company’s stock worth $2,893,000 after buying an additional 2,249 shares in the last quarter. Finally, Swiss National Bank grew its position in Neogen Corporation by 1.0% during the first quarter. Swiss National Bank now owns 62,350 shares of the company’s stock worth $4,087,000 after buying an additional 600 shares in the last quarter. Institutional investors and hedge funds own 86.10% of the company’s stock.

A number of analysts have recently weighed in on NEOG shares. BidaskClub downgraded Neogen Corporation from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 28th. Zacks Investment Research upgraded Neogen Corporation from a “hold” rating to a “buy” rating and set a $72.00 price objective for the company in a research report on Thursday, July 20th. Finally, CL King began coverage on Neogen Corporation in a research report on Friday, July 14th. They set a “neutral” rating for the company.

About Neogen Corporation

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.

Insider Buying and Selling by Quarter for Neogen Corporation (NASDAQ:NEOG)

Receive News & Ratings for Neogen Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Corporation and related companies with MarketBeat.com's FREE daily email newsletter.